IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SV Life Sciences Advisers, LLC

Q4 2017 Holdings

Filed 2018-02-14 | 8 holdings | $189.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Entellus MED IncCOM29363K105$72.1K2,956,45638.1%
Deciphera Pharmaceuticals Inc(DCPHEUR)COM24344T101$38.9K1,716,30320.6%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$25.2K2,579,49013.3%
Arsanis IncCOM042873109$23.8K1,868,96112.6%
Transenterix IncCOM NEW89366M201$14.6K7,546,6927.7%
Ocular Therapeutix Inc(OCUL)COM67576A100$7.1K1,605,2073.8%
Catabasis Pharmaceuticals inCOM14875P107$4.3K2,857,6672.2%
Reshape Life Sciences IncCOM29365M505$3.3K2,250,9581.8%